PPAT and nonpapillary renal cell carcinoma: In SETD2 mutant ccRCC, LEDGF recognized H3R17me2a and activated the transcription of key enzymes in the nucleotide de novo synthesis pathway such as PPAT, promoting the proliferation of ccRCC.